PNC Financial Services Group Inc. Has $852,000 Position in HealthEquity, Inc. (NASDAQ:HQY)

PNC Financial Services Group Inc. lessened its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 14.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,880 shares of the company’s stock after selling 1,529 shares during the period. PNC Financial Services Group Inc.’s holdings in HealthEquity were worth $852,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of HQY. GSA Capital Partners LLP bought a new position in HealthEquity in the 3rd quarter worth approximately $638,000. KBC Group NV grew its stake in shares of HealthEquity by 16.1% in the third quarter. KBC Group NV now owns 2,463 shares of the company’s stock worth $202,000 after acquiring an additional 341 shares during the last quarter. Natixis Advisors LLC increased its position in HealthEquity by 29.8% during the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after acquiring an additional 48,009 shares during the period. Mutual of America Capital Management LLC raised its stake in HealthEquity by 0.7% during the 3rd quarter. Mutual of America Capital Management LLC now owns 97,718 shares of the company’s stock valued at $7,998,000 after purchasing an additional 648 shares during the last quarter. Finally, Thrivent Financial for Lutherans boosted its holdings in HealthEquity by 33.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock valued at $24,033,000 after purchasing an additional 73,404 shares during the period. Institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Up 3.4 %

Shares of HealthEquity stock opened at $100.72 on Tuesday. The stock has a market capitalization of $8.73 billion, a P/E ratio of 92.40, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a 50-day simple moving average of $105.76 and a 200 day simple moving average of $95.51.

Insider Transactions at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.20% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Royal Bank of Canada lifted their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. Barrington Research reissued an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a report on Friday. Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Raymond James lifted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 25th. Finally, Mizuho began coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $112.92.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.